PCN13 ASSESSMENT OFTHE COST-EFFECTIVENESS IN AUSTRALIA OF CETUXIMAB IN THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CANCERS OFTHE HEAD AND NECK

Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65171-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)65171-6/fulltext
Section Title :
Section Order : 331
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65171-6&doi=10.1016/S1098-3015(10)65171-6
HEOR Topics :
Tags :
Regions :